The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
A Systematic Review of Adherence to Oral Antineoplastic Therapies
Open accessAbstract
Background.: Oral antineoplastic therapies not only improve survival but also reduce the burden of care for patients. Yet patients and clinicians face new challenges in managing adherence to these oral therapies. We conducted a systematic literature review to assess rates and correlates of adherence to oral antineoplastic therapies and interventions aimed at improving adherence. Methods.: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive literature search of the Ovid MEDLINE database from January 1, 2003 to June 30, 2015, using relevant terminology for oral antineoplastic agents. We included observational, database, and intervention studies. At least two researchers evaluated each paper to ensure accuracy of results and determine risk of bias. Results.: We identified 927 records from the search and screened 214 abstracts. After conducting a full-text review of 167 papers, we included in the final sample 51 papers on rates/correlates of adherence to oral antineoplastic therapy and 12 papers on intervention studies to improve adherence. Rates of adherence varied widely, from 46% to 100%, depending on patient sample, medication type, follow-up period, assessment measure, and calculation of adherence. Of the intervention studies, only 1 of the randomized trials and 2 of the cohort studies showed benefit regarding adherence, with the majority suffering high risk of bias. Conclusions.: Although no reliable estimate of adherence to oral antineoplastic therapies can be gleaned from the literature, a substantial proportion of patients struggle to adhere to these medications as prescribed. The few intervention studies for adherence have notable methodological concerns, thereby limiting the evidence to guide practice in promoting medication adherence among patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Adherence to Long‐Term Therapies: Evidence for Action
Burkhart, P. V., & Sabaté, E. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.tb00001.x · Cited by 2,526
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870
Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9655 · Cited by 828
Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Noens, L., van Lierde, M.-A., De Bock, R., Verhoef, G., Zachée, P., Berneman, Z., Martiat, P., Mineur, P., Van Eygen, K., MacDonald, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-196543 · Cited by 616
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.9.652 · Cited by 584
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
Partridge, A. H., LaFountain, A., Mayer, E., Taylor, B. S., Winer, E., & Asnis-Alibozek, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 482
NCCN Task Force Report: Oral Chemotherapy
Weingart, S. N., Brown, E., Bach, P. B., Eng, K., Johnson, S. A., Kuzel, T. M., Langbaum, T. S., Leedy, R. D., Muller, R. J., Newcomer, L. N., et al. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.2003 · Cited by 435
Neugut, A. I., Subar, M., Wilde, E. T., Stratton, S., Brouse, C. H., Hillyer, G. C., Grann, V. R., & Hershman, D. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3179 · Cited by 354
McCowan, C., Shearer, J., Donnan, P. T., Dewar, J. A., Crilly, M., Thompson, A. M., & Fahey, T. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604758 · Cited by 343
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Makubate, B., Donnan, P. T., Dewar, J. A., Thompson, A. M., & McCowan, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.116 · Cited by 298
Dilworth, S., Higgins, I., Parker, V., Kelly, B., & Turner, J. (2014) · Psycho-Oncology · doi:10.1002/pon.3474 · Cited by 286
Darkow, T., Henk, H. J., Thomas, S. K., Feng, W., Baladi, J.-F., Goldberg, G. A., Hatfield, A., & Cortes, J. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725060-00004 · Cited by 271
Oral cancer treatment: developments in chemotherapy and beyond
O'Neill, V. J., & Twelves, C. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600591 · Cited by 269
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
Ziller, V., Kalder, M., Albert, U.-S., Holzhauer, W., Ziller, M., Wagner, U., & Hadji, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn646 · Cited by 263
Adherence beliefs among breast cancer patients taking tamoxifen
Grunfeld, E. A., Hunter, M. S., Sikka, P., & Mittal, S. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2004.10.005 · Cited by 245
Ganesan, P., Sagar, T. G., Dubashi, B., Rajendranath, R., Kannan, K., Cyriac, S., & Nandennavar, M. (2011) · American Journal of Hematology · doi:10.1002/ajh.22019 · Cited by 196
Sedjo, R. L., & Devine, S. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0952-6 · Cited by 169
Neuss, M. N., Polovich, M., McNiff, K., Esper, P., Gilmore, T. R., LeFebvre, K. B., Schulmeister, L., & Jacobson, J. O. (2013) · Journal of Oncology Practice · doi:10.1200/jop.2013.000874 · Cited by 163
Partridge, A. H., Archer, L. E., Kornblith, A. B., Gralow, J. R., Grenier, D., Perez, E. A., Wolff, A. C., Wang, X., Kastrissios, H., Berry, D. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4671 · Cited by 153
The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
McCowan, C., Wang, S., Thompson, A. M., Makubate, B., & Petrie, D. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.464 · Cited by 137
Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care
Simons, S., Ringsdorf, S., Braun, M., Mey, U., Schwindt, P., Ko, Y. D., Schmidt‐Wolf, I. G. H., Kuhn, W. C., & Jaehde, U. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0927-5 · Cited by 135
Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., Donovan, H. S., Dunbar-Jacob, J., Jankowitz, R. C., Rosenzweig, M. Q., et al. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.274-285 · Cited by 131
Wigertz, A., Ahlgren, J., Holmqvist, M., Fornander, T., Adolfsson, J., Lindman, H., Bergkvist, L., & Lambe, M. P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1961-4 · Cited by 129
Spoelstra, S., Given, B. A., Given, C. W., GRANT, M. M., Sikorskii, A. E., You, M., & Decker, V. B. (2012) · Cancer Nursing · doi:10.1097/ncc.0b013e3182551587 · Cited by 128
Effective oral chemotherapy for breast cancer: pillars of strength
Findlay, M. P. N., von Minckwitz, G., & Wardley, A. M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm285 · Cited by 127
Wu, E. Q., Johnson, S., Beaulieu, N., Arana, M., Bollu, V., Guo, A., Coombs, J., Feng, W., & Cortes, J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903396469 · Cited by 126
Adherence to oral antineoplastic agents by cancer patients: definition and literature review
Bassan, F., Peter, F., Houbre, B., Brennstuhl, M., Costantini, M., Speyer, É., & Tarquinio, C. (2013) · European Journal of Cancer Care · doi:10.1111/ecc.12124 · Cited by 126
Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Lück, H.-J., Windemuth-Kieselbach, C., Zaun, S., & Kreienberg, R. (2013) · Annals of Oncology · doi:10.1093/annonc/mds653 · Cited by 122
Efficace, F., Baccarani, M., Rosti, G., Cottone, F., Castagnetti, F., Breccia, M., Alimena, G., Iurlo, A., Rossi, A. R., Pardini, S., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.348 · Cited by 119
Capecitabine non-adherence: Exploration of magnitude, nature and contributing factors
Bhattacharya, D., Easthall, C., Willoughby, K. A., Small, M., & Watson, S. J. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155211436022 · Cited by 118
The Challenges of Oral Agents as Antineoplastic Treatments
Given, B. A., Spoelstra, S., & GRANT, M. M. (2011) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2011.02.003 · Cited by 117
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients
Ma, A. M. T., Barone, J., Wallis, A. E., Wu, N. J., Garcia, L. B., Estabrook, A., Rosenbaum-Smith, S. M., & Tartter, P. I. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.06.027 · Cited by 115
Stanton, A. L., Petrie, K. J., & Partridge, A. H. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2961-3 · Cited by 113
Oral chemotherapy safety practices at US cancer centres: questionnaire survey
Weingart, S. N., Flug, J. A., Brouillard, D., Morway, L., Partridge, A. H., Bartel, S. B., Shulman, L. N., & Connor, M. (2007) · BMJ · doi:10.1136/bmj.39069.489757.55 · Cited by 110
Hershman, D. L., Tsui, J., Meyer, J., Glied, S., Hillyer, G. C., Wright, J. D., & Neugut, A. I. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju319 · Cited by 110
Adherence enhancing interventions for oral anticancer agents: A systematic review
Mathes, T., Antoine, S., Pieper, D., & Eikermann, M. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.07.004 · Cited by 90
Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review
Banning, M. (2011) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2011.01295.x · Cited by 88
Simon, R., Latreille, J., Matte, C., Desjardins, P., & Bergeron, É. (2014) · Canadian Journal of Surgery · doi:10.1503/cjs.006211 · Cited by 85
Ziller, V., Kyvernitakis, I., Knöll, D., Storch, A., Hars, O., & Hadji, P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-407 · Cited by 82
Font, R., Espinas, J. A., Gil-Gil, M., Barnadas, A., Ojeda, B., Tusquets, I., Segui, M. A., Margelí, M., Arcusa, A., Prat, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.389 · Cited by 79
Adherence to hormone therapy among women with breast cancer
Brito, C., Portela, M. C., & de Vasconcellos, M. T. L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-397 · Cited by 78
Adherence influencing factors in patients taking oral anticancer agents: A systematic review
Mathes, T., Pieper, D., Antoine, S.-L., & Eikermann, M. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.03.012 · Cited by 76
Hsieh, K., Chen, L., Cheung, K., Chang, C.-S., & Yang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087027 · Cited by 74
Weaver, K. E., Camacho, F., Hwang, W., Anderson, R. T., & Kimmick, G. G. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182436ec1 · Cited by 74
Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer
Xu, S., Yang, Y., Tao, W., Song, Y., Chen, Y., Ren, Y., Liu, J., & Pang, D. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2286-z · Cited by 74
Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients
Arriola, K. J., Mason, T. A., Bannon, K. A., Holmes, C. E., Powell, C. L., Horne, K., & O'Regan, R. M. (2014) · Patient Education and Counseling · doi:10.1016/j.pec.2013.12.019 · Cited by 70
Self-Reported Compliance with Capecitabine: Findings from a Prospective Cohort Analysis
Winterhalder, R., Hoesli, P., Delmore, G., Pederiva, S., Bressoud, A., Hermann, F., von Moos, R., & on behalf of the SAEDA Investigators Group (Swiss prospective cohort group) (2011) · Oncology · doi:10.1159/000328317 · Cited by 69
Wu, E. Q., Guérin, A., Yu, A. P., Bollu, V. K., Guo, A. X., & Griffin, J. D. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.533648 · Cited by 66
Gebbia, V., Bellavia, M., Banna, G. L., Russo, P., Ferraù, F., Tralongo, P., & Borsellino, N. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.11.007 · Cited by 60
van de Water, W., Bastiaannet, E., Hille, E. T. M., Kranenbarg, E. M., Putter, H., Seynaeve, C., Paridaens, R., de Craen, A. J. M., Westendorp, R. G. J., Liefers, G., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0037 · Cited by 57
Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.02.009 · Cited by 53
Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice
Santoleri, F., Sorice, P., Lasala, R., Rizzo, R. C., & Costantini, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056813 · Cited by 52
Moon, J. H., Sohn, S. K., Kim, S. N., Park, S. Y., Yoon, S. S., Kim, I. H., Kim, H. J., Kim, Y. K., Min, Y. H., Cheong, J., et al. (2011) · Medical Oncology · doi:10.1007/s12032-011-9926-8 · Cited by 51
A Tailored Nurse Coaching Intervention for Oral Chemotherapy Adherence
Schneider, S. M., Adams, D. B., & Gosselin, T. (2014) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2014.5.3.2 · Cited by 51
The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees
Neuner, J. M., Kamaraju, S., Charlson, J. A., Wozniak, E. M., Smith, E. C., Biggers, A., Smallwood, A. J., Laud, P. W., & Pezzin, L. E. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv130 · Cited by 50
Mayer, E. L., Partridge, A. H., Harris, L. N., Gelman, R. S., Schumer, S., Burstein, H. J., & Winer, E. P. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0366-5 · Cited by 49
Krolop, L., Ko, Y., Schwindt, P., Schumacher, C., Fimmers, R., & Jaehde, U. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003139 · Cited by 49
Jönsson, S., Olsson, B., Söderberg, J., & Wadenvik, H. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1359-0 · Cited by 46
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
Oberguggenberger, A., Sztankay, M. J., Beer, B., Schubert, B., Meraner, V., Oberacher, H., Kemmler, G., Giesinger, J. M., Gamper, E., Sperner‐Unterweger, B., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-474 · Cited by 45
MacIntosh, P. W., Pond, G. R., Pond, B., Leung, V., & Siu, L. L. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00758.x · Cited by 45
Trivedi, D., Landsman-Blumberg, P. B., Darkow, T., Smith, D. M., McMorrow, D., & Mullins, C. D. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.10.1006 · Cited by 42
Jönsson, S., Olsson, B., Söderberg, J., & Wadenvik, H. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3024-8 · Cited by 41
Sommers, R., Miller, K., & Berry, D. L. (2012) · Oncology nursing forum · doi:10.1188/12.onf.e373-e379 · Cited by 40
Coping with Chronic Illness: Workbook
Safren, S. A., Gonzalez, J. S., & Soroudi, N. (2007) · Oxford University Press eBooks · doi:10.1093/med:psych/9780195315158.001.0001 · Cited by 39
Self-citationMazzeo, F., Duck, L., Joosens, E. J., Dirix, L. Y., Focan, C., Forget, F., Geest, S. D., Muermans, K., van Lierde, M.-A., MacDonald, K., et al. (2011) · PubMed · Cited by 34
Weingart, S. N., Li, J. W., Zhu, J., Morway, L., Stuver, S. O., Shulman, L. N., & Hassett, M. J. (2012) · Journal of Oncology Practice · doi:10.1200/jop.2011.000379 · Cited by 33
Grundmark, B., Garmo, H., Zethelius, B., Stattin, P., Lambe, M. P., & Holmberg, L. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1290-x · Cited by 32
Adherence to imatinib therapy in gastrointestinal stromal tumors and chronic myeloid leukemia
Albarrak, J., & Cheung, W. Y. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1831-6 · Cited by 31
de Figueiredo, A. G., & Forones, N. M. (2014) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032014000300004 · Cited by 31
Guérin, A., Chen, L., Wu, E. Q., de Leon, D. P., & Griffin, J. D. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.705264 · Cited by 30
Ruddy, K. J., Pitcher, B., Archer, L. E., Cohen, H. J., Winer, E. P., Hudis, C. A., Muss, H. B., & Partridge, A. H. (2012) · Annals of Oncology · doi:10.1093/annonc/mds133 · Cited by 30
Thivat, É., Praagh, I. V., Belliere, A., Mouret‐Reynier, M., Kwiatkowski, F., Durando, X., Mahammedi, H., Dillies, A.-F., Chollet, P. J. M., & Chevrier, R. (2012) · Oncology · doi:10.1159/000342087 · Cited by 26
Lee, H. S., Lee, J., Ah, Y.-M., Kim, H. S., Im, S., Noh, D., & Lee, B. K. (2014) · Oncology · doi:10.1159/000360702 · Cited by 26
Klepin, H. D., Geiger, A. M., Bandos, H., Costantino, J. P., Rapp, S. R., Sink, K. M., Lawrence, J. A., Atkinson, H. H., & Espeland, M. A. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0165 · Cited by 25
Brier, M. J., Chambless, D. L., Gross, R., Su, H.-C. I., DeMichele, A. M., & Mao, J. J. J. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.113 · Cited by 23
Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma
Mallick, R., Cai, J. X., & Wogen, J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.842161 · Cited by 20
Adherence to adjuvant endocrine therapy in women with breast cancer
Danilak, M., & Chambers, C. R. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155212455939 · Cited by 18
Adherence to Anti-estrogen Therapy in Seniors with Breast Cancer: How Well are we Doing?
Trabulsi, N. H., Riedel, K., Winslade, N. E., Grégoire, J., Meterissian, S. H., Abrahamowicz, M., Tamblyn, R. M., Mayo, N. E., & Meguerditchian, A. N. (2014) · The Breast Journal · doi:10.1111/tbj.12328 · Cited by 18
Risks of nonadherence to hormone therapy in Asian women with breast cancer
Hsieh, K., Chen, L., Cheung, K., & Yang, Y. (2015) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.04.002 · Cited by 17
What Makes a Good Prevalence Survey?
Williams, H. C. (2014) · Wiley eBooks · doi:10.1002/9781118357606.ch13 · Cited by 11
What Makes a Good Prevalence Survey?
Radulescu, M., Diepgen, T. L., & Williams, H. C. (2008) · doi:10.1002/9781444300161.ch12 · Cited by 11
Harbeck, N., Blettner, M., Hadji, P., Jackisch, C., Lück, H., Windemuth-Kieselbach, C., Zaun, S., Haidinger, R., Schmitt, D. C., Schulte, H., et al. (2013) · Breast Care · doi:10.1159/000350777 · Cited by 7
Cited by
A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay
Gordon, L. G., Merollini, K. M. D., Lowe, A., & Chan, R. J. (2017) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-016-0204-x · Cited by 479
Lin, C., Clark, R., Tu, P., Bosworth, H. B., & Zullig, L. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4317-2 · Cited by 160
Toivonen, K., Williamson, T., Carlson, L., Walker, L., & Campbell, T. (2020) · Cancers · doi:10.3390/cancers13010107 · Cited by 77
“First, reviews that only report factors that are associated with adherence [12,15,16] and omit studies with null findings may overestimate the importance of these variables in understanding adherence.”
BackgroundMobile-based oral chemotherapy adherence-enhancing interventions: scoping review
Skrabal Ross, X., Gunn, K. M., Patterson, P., & Olver, I. (2018) · JMIR mhealth and uhealth · doi:10.2196/11724 · Cited by 24
(2024) · doi:10.2196/46979 · Cited by 17
Metadata
- Authors
- Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., Lennes, I., Temel, J. S., Safren, S. A., & Pirl, W. F.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-26
- Volume
- 21
- Issue
- 3
- Pages
- 354-376
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2284819073
- Cited by
- 344
- References
- 93
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.